Donor and product safety has improved significantly
over the last decade as a consequence of the introduction of
measures such as evidence-based blood donor selection criteria,
which take into account the precautionary principle
where appropriate and improved screening of blood donations
for infectious agents. However, the implementation of
underpinning quality assurance programmes based on
good manufacturing practice has also played a key role in
improving safety and quality of blood and blood components.